Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AV-1980R
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Institute for Molecular Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : AV-1980R, an anti-Tau recombinant protein vaccines targets Alzheimer's Disease and other Tau aggregation-associated neurodegenerative conditions by providing outstanding levels of antibody protection against harmful forms of Tau protein that may lead to ...
Product Name : AV-1980R
Product Type : Vaccine
Upfront Cash : Inapplicable
April 11, 2022
Lead Product(s) : AV-1980R
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Institute for Molecular Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable